ArticleFrontiers in endocrinology2025
Evaluating the association between gestational diabetes and neonatal hypoglycemia in Taiwan: a retrospective study of 2,149 pregnancies.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine whether gestational diabetes mellitus (GDM) is associated with an increased risk of neonatal hypoglycemia and adverse neonatal outcomes in a Taiwanese population. Methods: We performed a retrospective cohort study of 2,149 women who delivered at Chung Shan Medical University Hospital from 2019 to 2023. GDM was diagnosed by one-step 75-g oral glucose tolerance test (OGTT). Neonatal hypoglycemia was defined as blood glucose <45 mg/dL. Logistic regression was used to estimate odds ratios (ORs) for neonatal outcomes associated with GDM, adjusting for maternal age, body mass index (BMI), and parity. Other neonatal outcomes included preterm birth, low Apgar scores (≤7 at 1 or 5 minutes), neonatal intensive care unit (NICU) admission, or neonatal jaundice. Results: Of 2,149 pregnancies, 591 (27.5%) were diagnosed with GDM. Neonatal hypoglycemia occurred in 176 newborns (8.2%). The incidence of hypoglycemia was slightly lower in infants of GDM mothers (6.8%) compared to those of non-GDM mothers (8.7%), but this difference was not statistically significant (adjusted OR 0.70, 95% CI 0.48-1.02). GDM was also not significantly associated with other neonatal outcomes, including preterm birth, low Apgar scores, NICU admission, or neonatal jaundice, after adjusting for confounders. Conclusions: In this Taiwanese cohort with universal GDM screening and management, GDM was not linked to a higher risk of neonatal hypoglycemia or other immediate neonatal complications. These findings suggest that effective prenatal care and glycemic control may mitigate the neonatal risks traditionally associated with GDM, underscoring the importance of management and population-specific factors in outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.